Merck KGaA

XTRA:MRK Stock Report

Market Cap: €49.0b

Merck KGaA Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Belen Garijo Lopez

Chief executive officer

€6.8m

Total compensation

CEO salary percentage22.11%
CEO tenure10.5yrs
CEO ownershipn/a
Management average tenure6.4yrs
Board average tenure5.7yrs

Recent management updates

We Think Shareholders May Want To Consider A Review Of Merck KGaA's (ETR:MRK) CEO Compensation Package

Apr 19
We Think Shareholders May Want To Consider A Review Of Merck KGaA's (ETR:MRK) CEO Compensation Package

Recent updates

Merck KGaA's (ETR:MRK) Share Price Not Quite Adding Up

Jul 03
Merck KGaA's (ETR:MRK) Share Price Not Quite Adding Up

Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

Apr 25
Merck KGaA (ETR:MRK) Will Pay A Dividend Of €2.20

We Think Shareholders May Want To Consider A Review Of Merck KGaA's (ETR:MRK) CEO Compensation Package

Apr 19
We Think Shareholders May Want To Consider A Review Of Merck KGaA's (ETR:MRK) CEO Compensation Package

Is Merck KGaA (ETR:MRK) A Risky Investment?

Apr 09
Is Merck KGaA (ETR:MRK) A Risky Investment?

Some May Be Optimistic About Merck KGaA's (ETR:MRK) Earnings

Mar 14
Some May Be Optimistic About Merck KGaA's (ETR:MRK) Earnings

Merck KGaA (ETR:MRK) Just Released Its Full-Year Earnings: Here's What Analysts Think

Mar 09
Merck KGaA (ETR:MRK) Just Released Its Full-Year Earnings: Here's What Analysts Think

Risks To Shareholder Returns Are Elevated At These Prices For Merck KGaA (ETR:MRK)

Feb 10
Risks To Shareholder Returns Are Elevated At These Prices For Merck KGaA (ETR:MRK)

We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt

Dec 16
We Think Merck KGaA (ETR:MRK) Can Stay On Top Of Its Debt
author-image

AI-Driven Semiconductor Surge Powers Healthcare And Electronics To New Heights

Strong growth in semiconductor solutions and life sciences boosts Merck's Electronics and Process Solutions sectors, positively impacting future revenue and earnings.

Some Shareholders Feeling Restless Over Merck KGaA's (ETR:MRK) P/E Ratio

Oct 18
Some Shareholders Feeling Restless Over Merck KGaA's (ETR:MRK) P/E Ratio

Is There An Opportunity With Merck KGaA's (ETR:MRK) 44% Undervaluation?

Sep 05
Is There An Opportunity With Merck KGaA's (ETR:MRK) 44% Undervaluation?

Here's Why Merck KGaA (ETR:MRK) Can Manage Its Debt Responsibly

Jul 24
Here's Why Merck KGaA (ETR:MRK) Can Manage Its Debt Responsibly

CEO Compensation Analysis

How has Belen Garijo Lopez's remuneration changed compared to Merck KGaA's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

€3b

Dec 31 2024€7m€2m

€3b

Sep 30 2024n/an/a

€3b

Jun 30 2024n/an/a

€3b

Mar 31 2024n/an/a

€3b

Dec 31 2023€11m€2m

€3b

Sep 30 2023n/an/a

€3b

Jun 30 2023n/an/a

€3b

Mar 31 2023n/an/a

€3b

Dec 31 2022€11m€2m

€3b

Sep 30 2022n/an/a

€3b

Jun 30 2022n/an/a

€3b

Mar 31 2022n/an/a

€3b

Dec 31 2021€9m€1m

€3b

Sep 30 2021n/an/a

€3b

Jun 30 2021n/an/a

€3b

Mar 31 2021n/an/a

€2b

Dec 31 2020€7m€1m

€2b

Sep 30 2020n/an/a

€2b

Jun 30 2020n/an/a

€1b

Mar 31 2020n/an/a

€2b

Dec 31 2019€6m€1m

€1b

Sep 30 2019n/an/a

€1b

Jun 30 2019n/an/a

€1b

Mar 31 2019n/an/a

€938m

Dec 31 2018€7m€1m

€1b

Compensation vs Market: Belen's total compensation ($USD7.93M) is above average for companies of similar size in the German market ($USD5.39M).

Compensation vs Earnings: Belen's compensation has been consistent with company performance over the past year.

CEO

Belen Garijo Lopez (65 yo)

10.5yrs
Tenure
€6,785,000
Compensation

Mrs. Belen Garijo Lopez, M.D., is Chair of Executive Board and Chief Executive Officer of Merck KGaA since May 01, 2021. She served as Vice Chairman of the Executive Board and Deputy Chief Executive Office...

Leadership Team

NamePositionTenureCompensationOwnership
Belen Garijo Lopez
Chair of Executive Board & CEO10.5yrs€6.79mno data
Helene von Roeder
CFO & Member of Executive Board2yrs€3.52mno data
Kai Beckmann
CEO of Electronics & Member of the Executive Board14.3yrs€4.99mno data
Danny Bar-Zohar
Member of the Executive Board & CEO of Healthcareless than a yearno datano data
Jean Wirth
Member of the Executive Board & CEO Life Scienceless than a yearno datano data
Khadija Hammada
Member of the Executive Board & Chief People Officerless than a yearno datano data
Florian Schraeder
Head of Investor Relationsno datano datano data
Frank Gotthardt
Head of Corporate & Government Relations - Europe16.1yrsno datano data
Marc Horn
Head of Life Science Controllingno datano datano data
Michael Heckmeier
Head of the Display Materials Business Unit for Performance Materials8.3yrsno datano data
Hans-Joachim Neumann
Head of Integrated Supply Chain6.8yrsno datano data
Tina Sandmann
Head of Internal Auditing6yrsno datano data
6.4yrs
Average Tenure
55yo
Average Age

Experienced Management: MRK's management team is seasoned and experienced (6.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dietmar Oeter
Employee Representative Member of Supervisory Board11.2yrs€72.80kno data
Alexander Putz
Employee Representative Member of Supervisory Board5.2yrs€70.80kno data
Stefan Palzer
Independent Supervisory Board Member1.3yrs€56.40kno data
Barbara Lambert
Independent Member of Supervisory Board1.9yrs€148.40kno data
Michael Kleinemeier
Independent Chairman of Supervisory Board6.3yrs€191.30kno data
Anne Lange
Employee Representative Member of Supervisory Board6.3yrs€72.80kno data
Christian Raabe
Employee Representative Member of Supervisory Board6.3yrs€111.10kno data
Daniel Thelen
Independent Member of Supervisory Board6.3yrs€76.60kno data
Simon Thelen
Independent Member of Supervisory Board6.3yrs€72.80kno data
Birgit Biermann
Employee Representative Member of Supervisory Board3yrs€72.80kno data
Katja Vila
Independent Supervisory Board Member1.3yrs€89.90kno data
Michael Reinhart
Employee Representative Member of Supervisory Board1.3yrs€88.90kno data
5.7yrs
Average Tenure
54.5yo
Average Age

Experienced Board: MRK's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/11 19:47
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Merck KGaA is covered by 61 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Gerhard SchwarzBaader Helvea Equity Research
Odile RundquistBaader Helvea Equity Research